pubrio
Ochre Bio

Ochre Bio

United Kingdom · Research

Research

Pharmaceuticals

Biotechnology

Healthcare

Ochre Bio is a biotechnology company developing RNA therapies for chronic liver diseases. Using a combination of genomic deep phenotyping, precision RNA medicine, and testing in live human donor livers, Ochre is developing therapies for important liver health challenges, from increasing donor liver supply to reducing cirrhosis complications. To learn more, please visit www.ochre-bio.com.

Company Insights
Company Overview

2019

Founded

Research

Industry

United Kingdom

Location

2,910,662

Ranking

69 employees

Size

Similar Companies

Get full access to view complete information

Frequently Asked Questions Regarding Ochre Bio

Start your journey today

Start with the platform — or start with a conversation

Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​